SI1585810T1 - Postopek gojenja celic za proizvodnjo substanc - Google Patents

Postopek gojenja celic za proizvodnjo substanc

Info

Publication number
SI1585810T1
SI1585810T1 SI200331791T SI200331791T SI1585810T1 SI 1585810 T1 SI1585810 T1 SI 1585810T1 SI 200331791 T SI200331791 T SI 200331791T SI 200331791 T SI200331791 T SI 200331791T SI 1585810 T1 SI1585810 T1 SI 1585810T1
Authority
SI
Slovenia
Prior art keywords
glucose
limitation
dgl
order
culturing cells
Prior art date
Application number
SI200331791T
Other languages
English (en)
Slovenian (sl)
Inventor
Thomas Link
Ruth Essers
Kerstin Skopnik
Jochen Gatgens
Thomas Noll
Christian Wandrey
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SI1585810T1 publication Critical patent/SI1585810T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596Molecules with a "CD"-designation not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI200331791T 2002-11-27 2003-11-07 Postopek gojenja celic za proizvodnjo substanc SI1585810T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10255508A DE10255508A1 (de) 2002-11-27 2002-11-27 Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen
PCT/DE2003/003693 WO2004048556A1 (de) 2002-11-27 2003-11-07 Verfahren zur kultivierung von zellen zur produktion von substanzen
EP03767406A EP1585810B1 (de) 2002-11-27 2003-11-07 Verfahren zur kultivierung von zellen zur produktion von substanzen

Publications (1)

Publication Number Publication Date
SI1585810T1 true SI1585810T1 (sl) 2010-06-30

Family

ID=32318751

Family Applications (3)

Application Number Title Priority Date Filing Date
SI200331791T SI1585810T1 (sl) 2002-11-27 2003-11-07 Postopek gojenja celic za proizvodnjo substanc
SI200332473A SI2226381T1 (sl) 2002-11-27 2003-11-07 Postopek za gojenje celic za proizvodnjo snovi
SI200332602T SI2275530T1 (sl) 2002-11-27 2003-11-07 Postopek za gojenje celic za proizvodnjo snovi

Family Applications After (2)

Application Number Title Priority Date Filing Date
SI200332473A SI2226381T1 (sl) 2002-11-27 2003-11-07 Postopek za gojenje celic za proizvodnjo snovi
SI200332602T SI2275530T1 (sl) 2002-11-27 2003-11-07 Postopek za gojenje celic za proizvodnjo snovi

Country Status (12)

Country Link
US (2) US20060127975A1 (enExample)
EP (3) EP2275530B1 (enExample)
JP (2) JP4469283B2 (enExample)
AT (1) ATE462013T1 (enExample)
CY (2) CY1110267T1 (enExample)
DE (2) DE10255508A1 (enExample)
DK (2) DK2226381T3 (enExample)
ES (3) ES2340377T3 (enExample)
HU (1) HUE028862T2 (enExample)
PT (1) PT1585810E (enExample)
SI (3) SI1585810T1 (enExample)
WO (1) WO2004048556A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2312184T3 (es) 1997-03-21 2009-02-16 Chugai Seiyaku Kabushiki Kaisha Agentes preventivos terapeuticos para el tratamiento de esclerosis multiple, que contienen anticuerpos anti-receptores de il-6 antagonistas.
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
GB2401040A (en) * 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
US7429491B2 (en) * 2003-05-15 2008-09-30 Wyeth Restricted glucose feed for animal cell culture
PE20091174A1 (es) 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
DE102008002210A1 (de) * 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur fermentativen Herstellung von Erythropoietin
CN104928336B (zh) * 2009-10-26 2020-05-08 弗·哈夫曼-拉罗切有限公司 用于生产糖基化免疫球蛋白的方法
AU2016210748B2 (en) * 2009-10-26 2018-03-01 Chugai Seiyaku Kabushiki Kaisha Method for the production of a glycosylated immunoglobulin
AU2015203309B2 (en) * 2009-10-26 2016-05-05 Chugai Seiyaku Kabushiki Kaisha Method for the production of a glycosylated immunoglobulin
TWI537386B (zh) * 2009-12-22 2016-06-11 Dsm智慧財產有限公司 由發酵法獲得的6-胺己酸製備己內醯胺
EP2787007A3 (en) 2010-11-08 2015-03-11 F. Hoffmann-La Roche AG Subcutaneously administered ANTI-IL-6 receptor antibody
BR112015032960B1 (pt) 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
EP4512889A3 (en) 2014-03-19 2025-05-07 Pfizer Inc. Method of cell culture
CA3214798A1 (en) 2015-09-23 2017-03-30 Pfizer Inc. Cells and method of cell culture
JP2022513702A (ja) 2018-12-06 2022-02-09 ファイザー・インク 阻害剤産生が低下した細胞およびその使用方法
WO2025088516A1 (en) 2023-10-26 2025-05-01 Pfizer Inc. Method of forming multi-specific antibodies from homodimer antibodies and pharmaceutical product including multi-specific antibodies thus obtained

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657863A (en) * 1982-07-02 1987-04-14 Celanese Corporation Stabilization of a mutant microorganism population
JPH066054B2 (ja) * 1987-10-15 1994-01-26 帝人株式会社 動物細胞の培養方法
CA2078546A1 (en) * 1990-04-03 1991-10-04 Phillip W. Berman Methods and compositions for vaccination against hiv
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
WO1993022448A1 (en) * 1992-05-01 1993-11-11 Teijin Limited Fed batch culture method for protein secreting cells
GB9506249D0 (en) * 1995-03-27 1995-05-17 Karobio Ab Media for insect cell cultures
WO1998041611A1 (en) * 1997-03-20 1998-09-24 Regents Of The University Of Minnesota Process for the continuous culture of cells
US6338964B1 (en) * 1999-05-07 2002-01-15 Bayer Corporation Process and medium for mammalian cell culture under low dissolved carbon dioxide concentration

Also Published As

Publication number Publication date
JP4469283B2 (ja) 2010-05-26
EP1585810A1 (de) 2005-10-19
EP2275530A2 (de) 2011-01-19
HUE028862T2 (en) 2017-01-30
EP1585810B1 (de) 2010-03-24
US20060127975A1 (en) 2006-06-15
EP2226381B1 (de) 2016-03-09
JP5221573B2 (ja) 2013-06-26
JP2010110331A (ja) 2010-05-20
WO2004048556A1 (de) 2004-06-10
CY1117558T1 (el) 2017-04-26
ATE462013T1 (de) 2010-04-15
EP2275530B1 (de) 2019-08-07
DK1585810T3 (da) 2010-06-07
ES2340377T3 (es) 2010-06-02
SI2275530T1 (sl) 2019-11-29
EP2275530A3 (de) 2012-05-23
JP2006507821A (ja) 2006-03-09
DK2226381T3 (en) 2016-04-11
DE10255508A1 (de) 2004-06-17
ES2749217T3 (es) 2020-03-19
ES2567161T3 (es) 2016-04-20
SI2226381T1 (sl) 2016-05-31
CY1110267T1 (el) 2015-01-14
US20140329277A1 (en) 2014-11-06
DE50312554D1 (de) 2010-05-06
EP2226381A1 (de) 2010-09-08
PT1585810E (pt) 2010-05-05

Similar Documents

Publication Publication Date Title
CY1117558T1 (el) Μεθοδος για καλλιεργεια κυτταρων για παραγωγη ουσιων
WO2003089567A3 (en) Apparatus and method for a cell culture in a bioreactor at high cell concentration
DK1623019T3 (da) Begrænset glucosetilførsel til dyrecellekultur
EP1239041A3 (en) Method for producing L-amino acid using bacteria belonging to the genus Escherichia
EP1992687A3 (fr) Lignées de cellules aviaires utiles pour la production de substances d'intérêt
ATE397059T1 (de) Verfahren zur herstellung von l-lysin oder l- threonin unter verwendung von escherichia- bakterien mit abgeschwächter malatenzymaktivität
TR200401091T4 (tr) Gelişim faktörleri ve L-glutamin içeren hücre kültürü besiyeri
BRPI0516261A (pt) método para produzir uma substãncia básica por fermentação, e, caldo de fermentação ou produto de fermentação contendo uma substáncia básica
EP1571223A3 (en) L-cysteine-producing microorganism and a method for producing L-cysteine
BR0200285A (pt) Bactéria corineforme, e método para a produção de l-cisteìna
NO20006096L (no) Medium for dyrking av dyreceller og fremgangsmåte for fremstilling av protein ved anvendelse av de samme
DE60138127D1 (de) Stoffwechseländerungen in gärungen zur produktion rekombinanter proteine
CA2543118A1 (en) Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease
AU6560200A (en) Method for culturing and/or treating cells
ATE317442T1 (de) Verfahren zur züchtung von mikroorganismen die methanol metabolisieren
AU2001243667A1 (en) Method of aerating yeast prior to pitching
AU7298600A (en) Method for producing exopolysaccharides
TW200510011A (en) A method for regeneration of bone
WO2005054447A3 (en) Müller stem cells
EP2484759A3 (en) Methods of refolding mammalian glycosyltransferases
ATE341630T1 (de) Verwendung von pankreatischer procarboxypeptidase b zur herstellung von insulin
WO2005046581A3 (en) P18 in stem cell manipulations
AU2003242533A1 (en) Glutamine-free medium
DE59911877D1 (de) Verfahren zur verbesserung des gentransfers von genetischem material in säugerzellen durch die verwendung von p21 (waf-1)
GB9828624D0 (en) Production of proteins